There has been increasing interest in the possibility that live mycobacteria secrete antigens which may be relevant to rapid recognition of bacilli by cells of the immune system. This possibility was highlighted by the fact that many T-cell clones which recognize sonicated mycobacteria fail to recognize live ones and that peak production of protective T cells in the infected animal occurs only when organisms are rapidly multiplying (14, 18). Since secreted antigens are likely to have important protective roles, we have used [35S]methionine-labeled supernatants of 4-to 7-day-old cultures to identify proteins which are secreted or released by living metabolizing organisms of Mycobacterium tuberculosis and Mycobacterium bovis BCG (2, 3). Western blot analysis showed that antigens defined in supernatants of 3-to 5-day-old cultures constituted a small subset of those seen in supernatants of organisms cultured for longer periods, when leakage of material from dead organisms becomes important (1, 2).
Fibronectin (FN)-binding antigens are prominent components of short-term culture supernatants of Mycobacterium tuberculosis. In 3-day-old supernatants, a 30-kilodalton (kDa) protein was identified as the major FN-binding molecule. In 21-day-old supernatants, FN bound to a double protein band of 30 and 31 kDa, as well as to a group of antigens of larger molecular mass (57 to 60 kDa). FN-binding molecules in this size range, but not of 30 to 31 kDa, were also found in sonicates. We showed that the 31-and 30-kDa FN-binding bands correspond to components A and B of the BCG85 complex, previously shown to be abundant in culture supernatants of Mycobacterium bovis BCG. Thus, a polyclonal antibody to the BCG85 complex bound to the 30-and 31-kDa antigens and inhibited binding of FN to them on immunoblots of the culture filtrates. Similarly, FN bound to the purified components of the BCG85 complex, and this binding was blocked by the antibody. A monoclonal antibody, HYT27, also bound both to the BCG85 components A and B and to the 30-and 31-kDa FN-binding molecules of M. tuberculosis, but it did not block the binding of FN. Related molecules appear to be present on the surface of BCG and to mediate the binding of BCG to FN-coated plastic surfaces, since this binding could also be blocked by the polyclonal anti-BCG85 antibody and by the purified components of BCG85, particularly component A, but not by monoclonal antibody HYT27. The binding of these mycobacterial antigens to FN appears to be of very high affinity, and we suggest that this property of major secreted antigens of M. tuberculosis indicates an important role in mycobacterial disease and in the binding of BCG to tumor cells during immunotherapy of bladder cancer. There has been increasing interest in the possibility that live mycobacteria secrete antigens which may be relevant to rapid recognition of bacilli by cells of the immune system. This possibility was highlighted by the fact that many T-cell clones which recognize sonicated mycobacteria fail to recognize live ones and that peak production of protective T cells in the infected animal occurs only when organisms are rapidly multiplying (14, 18) . Since secreted antigens are likely to have important protective roles, we have used [35S]methionine-labeled supernatants of 4-to 7-day-old cultures to identify proteins which are secreted or released by living metabolizing organisms of Mycobacterium tuberculosis and Mycobacterium bovis BCG (2, 3) . Western blot analysis showed that antigens defined in supernatants of 3-to 5-day-old cultures constituted a small subset of those seen in supernatants of organisms cultured for longer periods, when leakage of material from dead organisms becomes important (1, 2) .
Some secreted antigens have the interesting property of binding to fibronectin (FN) (2) . FN, which is a large glycoprotein commonly found in plasma and extracellular matrix, has many biological activities. It binds to a number of macromolecules, including collagen, gelatin, fibrin, and heparin, and participates in cell surface interactions between eucaryotic cells and microorganisms (9, 12, 22) . FN has been observed to bind in a receptor-mediated manner to several bacteria and parasites including Staphylococcus aureus, Streptococcus pyogenes, and Treponema pallidum (5, 13, 20, 21) . It has been suggested that FN has a role as an * Corresponding author.
adherence factor important in the pathogenesis of infective endocarditis (6) .
We recently demonstrated that mycobacteria bound to FN and that BCG culture supernatants inhibited attachment of organisms to FN-coated surfaces (15) . Moreover, the attachment of BCG to the bladder wall was shown to be mediated by FN, suggesting that this interaction is necessary for the initiation of the antitumor activity in intravesical BCG therapy for murine bladder cancer (16) .
The aims of this study were to define the FN-binding antigens which are secreted or released by M. tuberculosis and M. bovis BCG and to establish their relationship to antigens of similar molecular weight described in other publications. These were the BCG85 complex which is abundant in culture supernatants of BCG (25) , antigens recognized by monoclonal antibodies of the HYT27 group in culture filtrates of M. tuberculosis (19, 27) , and an antigen designated P32 purified from BCG supernatant (4) .
We show here that these antigens are all related and that they also mediate the binding of whole organisms to FNcoated surfaces. These molecules must be present on the surface of the bacilli, as well as being secreted.
MATERIALS AND METHODS
Mycobacterial strains. The strains of M. tuberculosis used were a laboratory strain, H37Rv, and a clinical isolate. The British (Glaxo Pharmaceuticals, Ltd., Greenford, United Kingdom), Brazilian, and Canadian M. bovis BCG substrains were obtained commercially as lyophilized preparations.
proteins in culture supernatants of mycobacteria were obtained as described previously (2, 3 Other antigens. The BCG85 components were purified from 14-day-old culture filtrate of a Danish BCG strain as described in detail elsewhere (25) by combining ammonium sulfate precipitation with column chromatography. A 21-day-old culture filtrate of the Japanese BCG strain was kindly provided by S. Nagai, Osaka City University Medical School, Osaka, Japan. Sonicates of M. tuberculosis H37Rv and M. bovis BCG were prepared as described previously (17) . The sonicate of armadillo-grown Mycobacterium leprae was provided by R. J. W. Rees, National Institute for Medical Research, London, United Kingdom. The recombinant form of the 65-kilodalton (kDa) protein of BCG was a gift from J. D. A. van Embden, National Institute of Public Health and Environmental Hygiene, Bilthoven, The Netherlands.
FN. Human FN was purified from plasma by affinity chromatography on gelatin-Sepharose as described by Vuento and Vaheri (23) .
Production of antisera and monoclonal antibodies. Rabbit antiserum against the BCG85 complex of M. bovis BCG was produced as described previously (25) . The monoclonal antibodies used were HBT7, HYT27, HYT29, and HYT2; they were produced and characterized as previously described (19) . Antibodies to FN which were prepared by immunizing rabbits or goats with purified FN gave a monospecific response against human serum proteins in immunoelectrophoresis. FN Wells were washed and adherence of 35S-labeled proteins or 3H-labeled BCG was determined as described above. The monoclonal antibodies (HBT7, HYT27, HYT29, and HYT2) and anti-BCG85 antiserum were tested for inhibition of BCG attachment to FN-coated surfaces. 3H-labeled BCG were incubated with appropriate antibody concentrations for 1 h at 37°C, washed with phosphate-buffered saline, and then assayed for binding to FN. The effects of purified BCG85A and BCG85B antigens on the attachment of 3H-labeled BCG to FN was determined by adding each antigen (protein concentration ranging from 0.3 to 30 ,ug/ml) to wells coated with FN. The 65-kDa protein of BCG was used as a control at the same concentrations. After 1 h of incubation at 37°C, the wells were washed and 3H-labeled BCG were added as described.
Western blotting (immunoblotting). Antigen samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a discontinuous buffer system (11) on slab gels of 12.5% acrylamide. A mixture of standard protein markers (MW-SDS-200; Sigma Chemical Co., St. Louis, Mo.) was used for the determination of molecular mass. Proteins were transferred onto nitrocellulose paper with a semi-dry electroblotter (Ancos, Olstykke, Denmark) (10). Proteins were localized by staining with Aurodye, a colloidal gold solution (Janssen Life Sciences Products, Olen, Belgium). Nitrocellulose membranes were incubated with antibodies as described previously (2) . For the identification of FN-binding antigens, immunoblots were incubated with FN (50 p.g ml-') for 2 h at 37°C and probed with peroxidase-conjugated rabbit anti-FN immunoglobulin at a 1:500 dilution (DAKO A246). The specificity of anti-BCG85 antibodies and HYT monoclonal antibodies toward the FN-binding proteins was checked by incubating immunoblots of culture filtrate and purified BCG85 antigens with anti-BCG85 antiserum or HYT monoclonal antibodies first and then with FN and anti-FN antibodies. RESULTS FN-binding activity of secreted proteins.
[35S]methioninelabeled proteins from culture supernatants of M. tuberculosis H37Rv and two BCG substrains were incubated with FN-coated surfaces. Binding of radiolabeled proteins is shown in Fig. 1 . The radioactivity recovered from surfaces coated with bovine serum albumin (usually 50 to 85 cpm) was subtracted from values obtained from incubations with FN. Attachment of mycobacterial culture supernatants to FN reflected a dose-dependent binding, since increasing amounts of radioactive proteins bound to higher concentrations of FN (Fig. 1A) . At the FN concentration (125 ,g ml-') used throughout the study, similar amounts of radiolabeled proteins in mycobacterial culture supernatants were found to bind to FN. Moreover, pretreatment of FN-coated surfaces with anti-FN antiserum diminished attachment of labeled proteins by 50 to 70% (Fig. 1B) leprae sonicate was used to determine the binding specificity of FN. FN reacted with two sets of mycobacterial proteins (Fig. 2B, lanes 1 to 4) . FN bound to one set of antigens in the range of 57, 58, and 60 kDa in both culture filtrate and sonicate. The other group of antigens recognized by FN was only present in culture filtrate and was a double protein band with molecular masses of 30 and 31 kDa. FN reacted poorly with M. leprae sonicate (Fig. 2B, lane 5) . (Fig. 2C, lane 3) .
To antigens demonstrated that the double protein band binding to FN corresponds to the two purified components of the BCG85 complex (Fig. 3A and B (26) . These observations suggest that the 30-kDa protein is a secreted antigen of this organism too, but unstudied because it is essentially absent from sonicates of M. leprae and is depleted from the surface during the extraction procedures required to prepare this organism from armadillo tissues. The fact that potent antisera prepared against armadillo-grown M. leprae sonicate failed to show evidence of antibodies to these antigens is compatible with the evidence that they are secreted.
There is also direct evidence that these antigens evoke responses in human tuberculosis. In a recent study, tuberculin-positive volunteers showed significant lymphoproliferation and gamma interferon production to antigen P32, but no anti-P32 antibodies (8) . In contrast, high levels of immunoglobulin G to P32 and low blastogenesis were observed in patients with poor general health and advanced tuberculous lesions.
In conclusion, this study resolved the confusion surrounding a series of reports of antigens in the 30-to 31-kDa range and showed that these are all concerned with the same antigens, which have in addition the relevant biological property of high affinity for FN. Work is now in progress to clone the genes since preliminary data suggest a role in both leprosy and tuberculosis.
